Stryker sells T/Pump product line to C2Dx

C2Dx today announced that it has acquired Stryker’s T/Pump product line for an undisclosed amount.

The T/Pump product line provides localized temperature therapy for pain relief and patient comfort. It is used for orthopedic conditions, acute injuries, chronic pain and muscle strains. It can also be used for skin trauma, burns, contusions and other localized pain diagnoses like arthritis and neuritis.

T/Pump has controlled warming and cooling temperature settings and multiple treatment cycle options to allow therapy to be customized for each patient’s needs.

“Our leadership team has extensive experience leading all phases of Medical Device manufacturing,” C2Dx founder Kevin McLeod said in a news release. “We have proven ourselves with a very successful initial product offering, and now we are excited to offer another valuable product and further pursue C2Dx’s mission.”

Read more
  • 0

These 5 medtech companies made it into the top 200 of Forbes’ best places to work list

Johnson & Johnson, Steris, Philips, Fujifilm Holdings and Boston Scientific were recently named among Forbes’ best large employers in America, based on feedback from their employees.

Forbes partnered with a market research firm to survey 50,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their willingness to recommend their employer to friends and family and to nominate a business that wasn’t their own.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

These 5 medtech companies made it into the top 200 of Forbes’ best places to work list

Johnson & Johnson, Steris, Philips, Fujifilm Holdings and Boston Scientific were recently named among Forbes’ best large employers in America, based on feedback from their employees.

Forbes partnered with a market research firm to survey 50,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their willingness to recommend their employer to friends and family and to nominate a business that wasn’t their own.

Johnson & Johnson (NYSE:JNJ) ranked 84 out of the full list of 500. The New Brunswick, N.J.-based company has a 4.2 out of 5-star rating on the job board website Glassdoor. Johnson & Johnson, founded in 1886, employs over 132,000 people. Its medical device segment generated $25.96 billion in revenue in 2019.

Mentor, Ohio-based Steris (NYSE:STE) ranked 105 on Forbes’s list of the best large employers in America. The company has a 3.6 out of 5-star rating on Glassdoor. …

Read more
  • 0

Are smart knee implants the next big thing in ortho?

Orthopedic device industry watchers think so, and Zimmer Biomet appears set to be the first out of the gate this year through a partnership with the startup Canary Medical.

The Canary Health Implantable Reporting Processor (CHIRP) can go inside the tibial extension segment of a commercial knee prosthesis, shown here. [Image courtesy of Canary Medical]What do drug-eluting stents and “smart” implantable medical devices have in common? It turns out it’s a lot, at least according to Dr. Bill Hunter.

The founder and CEO of Angiotech Pharmaceuticals from 1992 to 2011, Hunter saw that medical device companies had cardiovascular stents that could save lives but also caused inflammation problems, while pharmaceutical companies had drugs that could stop the inflammation. He helped bring the technologies together, playing a role in the invention and development of the Taxus drug-eluting coronary stent from Boston Scientific and the Zilver PTX peripheral dr…

Read more
  • 0

Are smart knee implants the next big thing in ortho?

Orthopedic device industry watchers think so, and Zimmer Biomet appears set to be the first out of the gate this year through a partnership with the startup Canary Medical.

The Canary Health Implantable Reporting Processor (CHIRP) can go inside the tibial extension segment of a commercial knee prosthesis, shown here. [Image courtesy of Canary Medical]

What do drug-eluting stents and “smart” implantable medical devices have in common? It turns out it’s a lot, at least according to Dr. Bill Hunter.

The founder and CEO of Angiotech Pharmaceuticals from 1992 to 2011, Hunter saw that medical device companies had cardiovascular stents that could save lives but also caused inflammation problems, while pharmaceutical companies had drugs that could stop the inflammation. He helped bring the technologies together, playing a role in the invention and development of the Taxus drug-eluting coronary…

Read more
  • 0

3M, Abbott in top 50 of Fortune’s most admired companies list

[Photo by Guillermo Latorre on Unsplash]Medtech giants  3M (NYSE:MMM) and Abbott (NYSE:ABT) made it into the top 50 of Fortune‘s 2021 World’s Most Admired Companies list.

3M — a manufacturing conglomerate that also has one of the largest medical device businesses in the world — came in at No. 24, up from No. 29 in the 2020 list. Abbott meanwhile was No. 42, up from No. 52.

Both companies have been playing important roles in efforts to manage the COVID-19 pandemic.

3M is an important supplier of N95 masks and other protective gear for healthcare and other essential workers.

Abbott in early 2020 developed three molecular diagnostic tests for the SARS-CoV-2 virus within a 30-day time span. By the late summer, it won an FDA emergency use authorization in the late summer for its speedy BinaxNow COVID-19 Ag Card antigen test.

Other medical device companies making it into the Fortune most admired companies list include Boston Scientific (…

Read more
  • 0

DTW Podcast: CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4

In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream. Also, Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the group’s goals and invites entrepreneurs of color to apply for the group’s Pitch Contest.

The deadline is Feb. 5. Go to medtechcolor.org for more information.

Truist Securities Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies.

Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again.

Pharma Editor Brian Buntz returns to tell his story of his 10-days wearing a continuous glucose monitor from Dexcom. Buntz wrote about the exp…

Read more
  • 0

DTW Podcast: CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4

In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream.

Also, Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the group’s goals and invites entrepreneurs of color to apply for the group’s Pitch Contest.

The deadline is Feb. 5. Go to medtechcolor.org for more information.

Truist Securities Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies.

Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again.

Pharma Editor Brian Buntz returns to tell his story of his 10-days wearing a continuous glucose monitor from Dexcom. Buntz wrote …

Read more
  • 0

MedTech 100 roundup: January ends with a dip

After spending several weeks on the ascent, medtech stocks leveled out a bit to end January, ending a run of several new highs in 2021.

MassDevice‘s MedTech 100 index ended the week (Jan. 29) at 104.05 points, marking a -2.2% drop from the 106.4-point mark set at the end of the previous week (Jan. 22).

The index had previously reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 set on Feb. 19, 2020, and a 72.9% overall leap from the lowest point of 62.13 set on March 23, 2020.

However, the drop from that high point to medtech’s current position is approximately -3.1%, although the industry still remains well above its pre-pandemic high (12.7%) and its mid-pandemic low point (67.5%).

Here are some of the best-performing medtech stocks from 2020.

While medtech saw a slight decline from the previous week, both of the overall markets fared …

Read more
  • 0

Stryker beats the Street on earnings but misses on revenue in Q4

Stryker (NYSE:SYK) posted fourth-quarter earnings this evening that beat the consensus forecast on Wall Street, but the company missed slightly on revenue.

The Kalamazoo, Mich.–based orthopedic device giant — the world’s largest — reported profits of $568 million, or $1.49 per share, on sales of $4.262 billion for the three months ended Dec. 31, 2020, for a bottom-line slide of –21.7% on sales growth of 3.2% compared with Q4 2019.

Adjusted to exclude one-time items, earnings per share were $2.81, 26¢ ahead of The Street, where analysts were looking EPS of $2.55 on sales of $4.33 billion.

Orthopedic device companies have been especially hard-hit during the COVID-19 pandemic as hospitals and patients alike held off on elective procedures. But Stryker appears to have weathered the tough times better than its competitors. Sales ticked down –3.6%, to 14.351 billion, for all of 2020.

“In spite of COVID-19 outbreaks that intensified through t…

Read more
  • 0

FDA says to limit mask decontamination to 4 cycles

(Image courtesy of Brian McGowan on Unsplash)

Soon after healthcare workers began warning of personal protective equipment (PPE) shortages, companies and other organizations started claiming their decontamination systems could reprocess used filtering facepiece respirators (FFRs) such as N95s up to 20 times.

The FDA began issuing emergency use authorizations (EUAs) for FFR decontamination systems with a range of allowable cycles and major media organizations and nurses began to question the claims about the number of times an FFR could be safely decontaminated and reused. Companies, universities and other organizations gained EUAs for sterilizing masks up to 10 times (Sterilucent and Steris), and Stryker (up to two times), with a total of 13 organizations now holding 15 such EUAs.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

January 2021 Issue: The Leadership in Medical Technology Issue

9 lessons in crisis management from Stryker CEO Kevin Lobo

These 10 stories mattered the most for medtech in 2020

How ResMed is advancing sleep and respiratory care

How Dexcom CEO Kevin Sayer is leading the company forward

Black engineers group works to promote diversity in medtech, equity in healthcare

Taking the guesswork out of tracking high blood pressure

Medtronic CEO Geoff Martha explains the importance of competition

Lessons learned help medtech move ahead

The most unsettling year that most anyone can remember had some upsides. We learned more than we wanted about a virus that continues to surpri…

Read more
  • 0